The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 31, Issue 6, Pages 924-932
Publisher
Wiley
Online
2016-04-27
DOI
10.1002/mds.26613
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI)
- (2015) Mike A. Nalls et al. MOVEMENT DISORDERS
- NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases
- (2015) Mike A. Nalls et al. NEUROBIOLOGY OF AGING
- Neuroimaging biomarkers for Parkinson disease: Facts and fantasy
- (2014) Joel S. Perlmutter et al. ANNALS OF NEUROLOGY
- Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study
- (2014) C. H. Adler et al. NEUROLOGY
- Salivary DJ-1 could be an indicator of Parkinson's disease progression
- (2014) Wen-Yan Kang et al. Frontiers in Aging Neuroscience
- Genetics and genomics of Parkinson’s disease
- (2014) Michelle K Lin et al. Genome Medicine
- Proteomic Analysis of the Cerebrospinal Fluid of Parkinson's Disease Patients Pre- and Post-Deep Brain Stimulation
- (2013) Er-Song Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- LRRK2 secretion in exosomes is regulated by 14-3-3
- (2013) K. B. Fraser et al. HUMAN MOLECULAR GENETICS
- How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale
- (2013) Glenn T. Stebbins et al. MOVEMENT DISORDERS
- A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
- (2013) Penelope G. Foulds et al. Scientific Reports
- Activity enhances dopaminergic long-duration response in Parkinson disease
- (2012) U. Jung Kang et al. NEUROLOGY
- Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease
- (2011) Ivana Devic et al. BRAIN
- Identification of blood microRNAs associated to Parkinsońs disease
- (2011) Regina Margis et al. JOURNAL OF BIOTECHNOLOGY
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- The Parkinson Progression Marker Initiative (PPMI)
- (2011) Kenneth Marek et al. PROGRESS IN NEUROBIOLOGY
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
- (2010) Min Shi et al. ANNALS OF NEUROLOGY
- The Clinically Important Difference on the Unified Parkinson's Disease Rating Scale
- (2010) Lisa M. Shulman et al. ARCHIVES OF NEUROLOGY
- Frequency of Known Mutations in Early-Onset Parkinson Disease
- (2010) Roy N. Alcalay et al. ARCHIVES OF NEUROLOGY
- Mild cognitive impairment in Parkinson disease: A multicenter pooled analysis
- (2010) D. Aarsland et al. NEUROLOGY
- 2009 Biospecimen Research Network Symposium: Advancing Cancer Research through Biospecimen Science
- (2009) H. M. Moore et al. CANCER RESEARCH
- Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients
- (2009) Yoshiro Saito et al. NEUROSCIENCE LETTERS
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
- (2008) Z. Gan-Or et al. NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started